(Q39781539)

English

Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients

scientific article published on March 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients (English)

1 reference

Europe PubMed Central

14 September 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Dixon R

1

1 reference

Europe PubMed Central

14 September 2017

Pozniak AL

2

1 reference

Europe PubMed Central

14 September 2017

Watt HM

3

1 reference

Europe PubMed Central

14 September 2017

Rolan P

4

1 reference

Europe PubMed Central

14 September 2017

Posner J

5

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

1 March 1996

1 reference

Europe PubMed Central

14 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

14 September 2017

40

1 reference

Europe PubMed Central

14 September 2017

3

1 reference

Europe PubMed Central

14 September 2017

556-560

1 reference

Europe PubMed Central

14 September 2017

Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

22 September 2017

Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

22 September 2017

Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

22 September 2017

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

25 September 2017

Examination of some factors responsible for a food-induced increase in absorption of atovaquone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

15 June 2018

Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

15 June 2018

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163157

15 June 2018

Identifiers

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39781539&oldid=2143822012"